S-Equol in Alzheimer's Disease (SEAD) Trial
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2016
At a glance
- Drugs AUS 131 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms SEAD
- 12 Aug 2016 Status changed from recruiting to completed.
- 01 Feb 2016 Planned end date changed from 1 Jun 2016 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 01 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.